Rheumatology

Multicentre trial shows semaglutide reduces body weight, knee pain and analgesic use, and improves physical function in patients with obesity and knee osteoarthritis pain.

Get the info you need on this new product, part of our drug news roundup for September.

Which statement about the use of corticosteroids in adults with rheumatoid arthritis is FALSE? 

Canadian Rheumatology Association updates its living guidelines with the addition of three new recommendations for glucocorticoid use in rheumatoid arthritis.

Some reduce risk more than others.

Canadian Rheumatology Association’s “living” treatment recommendations provide contemporary guidance on the management of patients with axial spondyloarthritis.

The presence of certain proteins could act as an alarm signal announcing the disease before it reaches the acute phase.

Descriptions of flare-related nightmares in the study often involved being attacked, trapped, crushed or falling.